[HTML][HTML] The per-patient costs of HIV services in South Africa: systematic review and application in the South African HIV investment case

G Meyer-Rath, C van Rensburg, C Chiu, R Leuner… - PloS one, 2019 - journals.plos.org
Background In economic analyses of HIV interventions, South Africa is often used as a case
in point, due to the availability of good epidemiological and programme data and the global …

[PDF][PDF] Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low-and middle-income countries

M Siapka, M Remme, CD Obure… - Bulletin of the World …, 2014 - SciELO Public Health
Objective To synthesize the data available–on costs, efficiency and economies of scale and
scope–for the six basic programmes of the UNAIDS Strategic Investment Framework, to …

[HTML][HTML] Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation

NA Menzies, T Cohen, HH Lin, M Murray… - PLoS …, 2012 - journals.plos.org
Background The Xpert MTB/RIF test enables rapid detection of tuberculosis (TB) and
rifampicin resistance. The World Health Organization recommends Xpert for initial diagnosis …

[HTML][HTML] Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050

R Granich, JG Kahn, R Bennett, CB Holmes, N Garg… - PloS one, 2012 - journals.plos.org
Background Antiretroviral Treatment (ART) significantly reduces HIV transmission. We
conducted a cost-effectiveness analysis of the impact of expanded ART in South Africa …

[HTML][HTML] Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study

JAC Hontelez, MN Lurie, T Bärnighausen… - PLoS …, 2013 - journals.plos.org
Background Expanded access to antiretroviral therapy (ART) using universal test and treat
(UTT) has been suggested as a strategy to eliminate HIV in South Africa within 7 y based on …

The cost of providing comprehensive HIV treatment in PEPFAR-supported programs

NA Menzies, AA Berruti, R Berzon, S Filler, R Ferris… - Aids, 2011 - journals.lww.com
Background: PEPFAR, national governments, and other stakeholders are investing
unprecedented resources to provide HIV treatment in developing countries. This study …

Cost-effectiveness of provider-based HIV partner notification in urban Malawi

SE Rutstein, LB Brown, AK Biddle… - Health policy and …, 2014 - academic.oup.com
Provider-initiated partner notification for HIV effectively identifies new cases of HIV in sub-
Saharan Africa, but is not widely implemented. Our objective was to determine whether …

The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa

S Rosen, L Long, I Sanne - Tropical medicine & international …, 2008 - Wiley Online Library
Objective Estimate the average outpatient cost per patient in care and responding to
treatment 1 year after initiation of antiretroviral therapy (ART) under different models of …

[HTML][HTML] The determinants of HIV treatment costs in resource limited settings

NA Menzies, AA Berruti, JM Blandford - PloS one, 2012 - journals.plos.org
Background Governments and international donors have partnered to provide free HIV
treatment to over 6 million individuals in low and middle-income countries. Understanding …

ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics

BA Larson, M Bii, S Henly‐Thomas… - Journal of the …, 2013 - Wiley Online Library
Introduction After almost 10 years of PEPFAR funding for antiretroviral therapy (ART)
treatment programmes in Kenya, little is known about the cost of care provided to HIV …